Transcript
Page 1: Kristina Finsaas poster 2010 - Environmental Health · 2019-12-16 · The$ Aryl$ hydrocarbon$ receptor$ (AhR)$ is$ aligand7ac8vated$ transcrip8on$ factor$ that when$ ac8vated,$ results$

The   Aryl   hydrocarbon   receptor   (AhR)   is   a   ligand-­‐ac8vated  transcrip8on   factor   that   when   ac8vated,   results   in  immunomodula8on.  Dendri8c  cells  (DCs)  are  important  immune  cells  involved   in   innate   and   adap8ve   immune   responses.   Currently,   it   is  not  fully  understood  if  different  AhR  ligands  differen8ally  affect  DCs.  We  hypothesized   that  DC   ac8va8on  will   be   inhibited   following  AhR  ac8va8on   in  an  AhR   ligand-­‐specific  manner.  To   test   this  hypothesis,  we  evaluated  the  effects  of  five  disparate  AhR  ligands:  TCDD,  Benzo(a)pyrene,  FICZ,  Indole-­‐3-­‐carbinol  and  Indirubin  on  LPS-­‐s8mulated  DC  2.4   cells.  Altera8ons   in  DC  accessory  molecules   (CD40,  CD80,  CD86  and  MHC  class  I)  and  the  produc8on  of  inflammatory  mediators  (IL-­‐6,  TNF-­‐α   and   nitric   oxide)   were   assessed.   Cell   number   and   viability  were  assessed  following  treatment  with  all  five  compounds.  All  AhR  ligands   decreased   the   LPS-­‐s8mulated   produc8on   of   the   pro-­‐inflammatory   cytokines,   IL-­‐6   and   TNF-­‐α,   by   the   cultured  DCs  while  only  Indole-­‐3-­‐carbinol  and  Indirubin  inhibited  the  genera8on  of  nitric  oxide.   As   expected,   LPS   increased   the   rela8ve   expression   of   MHC  class   I,   CD40,   CD80   and   CD86   on   the   DC2.4   cells.   Rela8ve   to   the  vehicle-­‐treated  controls,  TCDD  increased  the  expression  of  CD40  and  CD80;  Benzo(a)pyrene  decreased  CD80;   FICZ  did  not   change  any  of  the   accessory   molecules;   Indole-­‐3-­‐carbinol   decreased   CD80   and  CD86;   and   Indirubin   decreased   all   four   surface   molecules.  Collec8vely,   these   results   suggest   that   DCs   respond   differently   to  these  five  dis8nct  AhR  ligands,  effects  that  are  ul8mately  expected  to  alter  the  genera8on  of  immune  responses  mediated  by  DCs.  

Abstract  

AhR  Ligand-­‐Specific  Effects  on  Dendri8c  Cell  Ac8va8on  Kris8na  Finsaas,  Andrea  Miller,  and  David  Shepherd  

Center  for  Environmental  Health  Sciences,  Department  of  Biomedical  &  Pharmaceu8cal  Sciences,  University  of  Montana,  Missoula,  MT  59812  

DC  2.4  cells  

Treatment  Groups:  Uns8mulated  &  LPS-­‐s8mulated  Vehicle  control  (DMSO  0.01%)  AhR  ligands:    TCDD  (10  nM)                                                  BaP  (10  µM)                                                  FICZ  (10  nM)                                                  IC3  (50  µM)                                                  INDR  (1  µM)                                                  

Pro-­‐inflammatory  mediators  IL-­‐6,  TNF-­‐α  and  nitric  oxide  (NO)  

Accessory  molecules  CD40,  CD80,  CD86  and  MHC  class  I  

CD86  

DC  

CD40  

CD80  

MHC  I  

TNF-­‐α  

IL-­‐6   DC  

Materials  and  Methods  

Figure  3:    DC2.4  cells  were  seeded  at  0.5x106  cells/mL/well  into  6-­‐well  plates  (n=4).  Cells  were  either  treated  with  Vehicle,  TCDD,  BaP,  FICZ,  I3C  and  INDR,  and  incubated  for  48  hours.  Ajer  harvest,  inflammatory  mediator  produc8on    and  cell  surface  molecule  expression  were  evaluated  by  ELISA  or  flow  cytometry,  respec8vely.          

Introduc<on  Dendri8c   cells   are   very   important   cells   in   the   immune   system.   They   are  responsible   for   the   uptake   and   presenta8on   of   an8gens   from   the   8ssue  periphery  to  T  cells,  enabling  the  genera8on  of  the  adap8ve  immune  response  and  the  elimina8on  of  microbial  pathogens.  But  this  process  can  be  interrupted  by  exposure  to  AhR  ligands,  changing  how  the  immune  system  func8ons.  Thus,  the  AhR  plays  an  integral  role  in  how  the  adap8ve  immune  system  responds  to  different  chemicals  in  the  environment.                  

The   Aryl   hydrocarbon   receptor   (AhR)   is   a   ligand-­‐ac8vated   transcrip8on   factor  found   in   the   cytosol.   The   AhR   is   a   common   pathway   that   mediates   the  immunotoxicity   of   many   xenobio8cs.   However,   it   is   not   currently   understood  how  various  AhR  ligands  affect  DCs  or  the  immune  system.  

• 2,3,7,8-­‐Tetrachlorodibenzo-­‐p-­‐dioxin  (TCDD)  • Halogenated  aroma8c  hydrocarbon  (HAH)  • Formed  by  industrial  processes  • Prototypical  AhR  ligand  

• Benzo[a]pyrene  (BaP)  • Polycyclic  aroma8c  hydrocarbon  (PAH)  • By-­‐product  of  automobile  exhaust  and  cigarene  smoke  • Strong  AhR  ligand    

• 6-­‐formylindolo[3,2-­‐b]carbazole  (FICZ)  • Natural  AhR  ligand  • Tryptophan  metabolite  

• Indole-­‐3-­‐carbinol  (IC3)  • Natural  AhR  ligand  • Found  in  cruciferous  vegetables  

• Indirubin-­‐3’-­‐oxime  (INDR)  • Natural  AhR  ligand  • Found  in  the  indigo  plant  and  commonly  used  in  tradi8onal  Chinese  medicine  

This  study  inves8gated  the  effects  of  TCDD,  BaP,  FICZ,   IC3,  and  INDR  on  DCs  by  evalua8ng  the  changes  that  occur  following  DC  ac8va8on  by  LPS,  a  cons8tuent  of   gram-­‐nega8ve   bacterial   cell   walls.   This   study   primarily   serves   to   further  establish   the   effects   of   AhR   ac8va8on   in   DCs   and   model   how   immune   cells  respond  to  environmental  toxic  pollutants  during  bacterial  infec8on.      

 Dendri<c  Cell  Number  and  Viability  

Figure  4:  Cell  number  and  viability  was  calculated  for  each  treatment  group  ajer  a  48hr  incuba8on  period.  Despite  changes  in  cell  number,  cell  viability  stays  rela8vely  constant  across  all  treatment  groups.    

The  project  described  was  supported  by  Award  Number  R25ES016247  and  R01ES13847  (DMS)  from  the  Na8onal  Ins8tute  Of  Environmental  Health  Sciences.  The  content  is  solely  the  responsibility  of  the  authors  and  does  not  necessarily  represent  the  official  views  of  the  Na8onal  Ins8tute  Of  Environmental  Health  Sciences  or  the  NIH.  Thanks  to  Jenna  Benson  and  Tom  Simones  for  their  assistance  in  data  presenta8on.  

Acknowledgements  

Conclusions  • I3C  and  INDR  inhibit  DC  prolifera8on.  • At  the  concentra8ons  tested,  all  five  AhR  ligands  are  not  cytotoxic.  • AhR  ac8va8on  in  DCs  anenuates  the  produc8on  of  IL-­‐6  and  TNF-­‐α.    • Accessory  molecules  were  most  sensi8ve  to  INDR>TCDD=I3C>BaP>FICZ.  • DCs  are  sensi8ve  to  AhR  ac8va8on.    Pro-­‐inflammatory  Mediator  Produc<on  

Figure  5:  The  effects  of  a  panel  of  AhR  ligands  on  the  produc8on  of  IL-­‐6,  TNF-­‐α  and  nitric  oxide  (NO)  by  DC2.4  cells.  DCs  were  uns8mulated  or  s8mulated  with  LPS  for  48  hrs,  supernatants  collected  and  analyzed  by  ELISA  (IL-­‐6  and  TNF-­‐α)  or  the  Greiss  reac8on  (NO).    

 *  significant  difference  uns8mulated  vs.  LPS    #  significant  difference  treated  groups  vs.  respec8ve  control      

RESULTS  Summary  

• I3C  and  INDR  increased  DC2.4  cell  numbers  following  LPS  ac8va8on.  • No  effects  were  observed  on  DC  viability  following  treatment  with  all  five  AhR  ligands.  • All  AhR  ligands  examined  decreased  the  LPS-­‐s8mulated  produc8on  of  the  pro-­‐inflammatory  cytokines,  IL-­‐6  and  TNF-­‐α.  • I3C  and  INDR  inhibited  the  produc8on  of  nitric  oxide.  • TCDD  increased  expression  of  CD40  and  CD80.  • BaP  decreased  CD80.  • FICZ  did  not  affect  any  of  the  accessory  molecules  tested.  • I3C  decreased  CD80  and  CD86.  • INDR  decreased  MHCI,  CD40,  CD80  and  CD86.  

Future  Direc<ons  •   Examine  bone  marrow-­‐derived  dendri8c  cells  (BMDCs)  to  establish  if  primary  DCs  are  affected  similar  to  DC2.4  cells.  •   Determine  if  the  AhR  ligand-­‐specific  effects  in  DCs  are  AhR-­‐dependent  by  using  BMDCs  from  AhR  knockout  mice.  •   Determine  if  these  different  ligands  mediate  their  specific  effects  via  the  canonical  or  non-­‐canonical  AhR  signaling  pathways.  • Assess  cell  cycle  changes  in  the  DCs  ajer  AhR  ac8va8on.          

AhR  Signaling  Pathway  

Figure  2:  When  bound  by  an  AhR  ligand,  the  AhR  can  be  ac8vated  by  two  signaling  pathways.  In  the  canonical  pathway,  AhR  dissociates  from  its  chaperone  proteins  and  migrates  to  the  nucleus  where  it  heterodimerizes  with  the  Aryl  hydrocarbon  receptor  nuclear  translocator  (ARNT)  and  modulates  gene  transcrip8on  via  Dioxin  response  elements  (DREs).  In  the  non-­‐canonical  pathway,  AhR  can  alter  NF-­‐κB  signaling,  ul8mately  affec8ng  transcrip8on.    

transcrip8on  mRNA  

Hsp90  

Hsp90  TCDD  TCDD  

TCDD  

AhR  

AhR  

ARNT  

transla8on  

TOXIC  RESPONSE  Cell  membrane  

nucleus  

NF-­‐κB  

Role  of  Dendri<c  Cells  in  the  Immune  System  

Figure  1:  Dendri8c  cells  are  integral  cellular  contributors  to  innate  and  adap8ve  immune  responses.  

Experiment  1   Experiment  2  

IL-6 Production

0

100

200

300

400

500

600*

** *

##

#

TNF-! Production

0

250

500

750 *

* * *#

##

NO- Production

0

25

50

75 * * * *

Cos<mulatory  Molecule  Expression  

 US=388.5±42  LPS=508.25±33  

US=510.75±22  LPS=1630.25±134  

US=  584.75±55  LPS=1047.75±57  

US=706.25±36  LPS=740.75±96  

US=791±29  LPS=708±31  

US=1620±28  LPS=2352±70  #  

US=1114±18  LPS=1522±17  #  

US=914±18  LPS=3863±84    

US=753±71  #  LPS=603±10  #  

US=1073±58  LPS=2357±78  #  

US=1142±80  LPS=1551±60  #  

US=1826±45  #  LPS=2901±92  #  

US=391±20  LPS=542.75±28  

US=522.75±19  LPS=1944.5±201  #   US=678±27  

LPS=624.75±65  #  US=624.25±18  LPS=1124.5±60  

US=439±92  LPS=464±45  

US=516.75±44  LPS=1223.5±221  #  

US=8029.25±731  #  LPS=8772±1053  #  

US=1005.25±415  LPS=835.75±172  

US=357.5±28  LPS=575±120  

US=460±16  LPS=1564.5±37  

US=648±15  LPS=1066.5±22  

US=778.75±129  LPS=831±368  

 *  significant  difference  uns8mulated  vs.  LPS    #  significant  difference  treated  groups  vs.  respec8ve  control      

Num

ber  of  events  

Rela8ve  Expression  

Figure  6:  The  effects  of  a  panel  of  AhR  ligands  on  the  expression  of  CD40,  CD80,  CD86  and  MHC  I  by  DC  2.4  cells.  DCs  were  treated  with  LPS  and  Vehicle,  TCDD,  BaP,  FICZ,  I3C,  INDR  for  48hrs.  Cells  were  harvested,  blocked  for  non-­‐specific  staining,  and  labeled  with  op8mally  8trated  monoclonal  an8bodies  specific  for  the  accessory  molecules.  DC2.4  cells  were  then  analyzed  on  a  BD  Biosciences  Aria  Flow  cytometer  and  representa8ve  histograms  generated  using  FlowJo  sojware.  Individual  histograms  are  shown  with  corresponding  mean  values  ±  SEM  for  all  treatment  groups.  

IL-6 Production

0

1000

2000

3000

4000

5000

6000

**

*#

#

##

**

*

TNF-! Production

0

500

1000

1500

2000

2500

3000

3500 *

*

#

# BD

BD

NO- Production

0

10

20

30 * *

*

*#

#

#

# • GREEN  –  AhR  dependent  increase  • RED  –  AhR  dependent  decrease  

Activation

T cells

 Cytokine    Produc8on  

Cytokine    Produc8on  

Innate  Immunity  

Adap8ve  Immunity  

Pathogen  Uptake  

Immature    Dendri8c  Cell    

Mature    Dendri8c  Cell  

Adap<ve  Immunity  

NO  

Top Related